Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Statistical Methods for Analyzing Epidemiological Data

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study.

Journal of clinical nursing·2026

Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026

Same author

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

Therapeutic advances in neurological disorders·2026

Same author

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Therapeutic advances in neurological disorders·2026

Same author

HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.

Journal of neurology·2026

Same journal

Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis.

Journal of neurology·2026

Same journal

Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.

Journal of neurology·2026

Same journal

Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth disease.

Journal of neurology·2026

Same journal

Migraine and auditory dysfunction: beyond comorbidity.

Journal of neurology·2026

Same journal

Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.

Journal of neurology·2026

Same journal

Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.

Journal of neurology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Big multiple sclerosis data network: novel modelling approaches for real-world data analysis.

M Trojano¹, P Iaffaldano², M Copetti³

¹Department of Translational Biomedicine and Neurosciences -DiBrain, University of Bari "Aldo Moro", Piazza Umberto I, 70121, Bari, Italy. maria.trojano@uniba.it.

Journal of Neurology

|November 8, 2025

Summary

This summary is machine-generated.

Advanced statistics and machine learning improve multiple sclerosis (MS) treatment predictions using real-world data (RWD). These methods enhance comparative effectiveness, safety analysis, and data harmonization for precision medicine in MS.

Keywords:

Big Data Computational methodologies Multiple Sclerosis Real-world data Statistical methodologies

More Related Videos

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Published on: November 1, 2019

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms

Published on: November 1, 2019

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

Statistical methodology
Real-world data analysis
Multiple Sclerosis research

Background:

The Big Multiple Sclerosis Data (BMSD) network convened a workshop in Bari, Italy, in June 2023.
The workshop focused on advanced statistical approaches for analyzing real-world data (RWD) in multiple sclerosis (MS).
The BMSD network includes five national registries and the international MSBase database, encompassing over 350,000 patients.

Purpose of the Study:

To report on the outcomes of the BMSD statistics workshop.
To highlight advanced statistical methods for RWD analysis in MS.
To discuss the application of these methods in predicting treatment response, comparative effectiveness, safety, and data harmonization for federated analyses.

Main Methods:

Experts reviewed frequentist, Bayesian, and machine learning (ML) approaches for RWD analysis.
Case studies included treatment response modeling, comparative effectiveness, safety surveillance, and Common Data Model (CDM)-based federated learning.
Discussion covered strengths, limitations, and regulatory implications of various statistical techniques.

Main Results:

Bayesian and ML techniques, combined with causal inference, enhance personalized predictions of treatment benefits and risks using longitudinal data.
Propensity score methods and marginal structural models are crucial for minimizing confounding in comparative analyses.
A Common Data Model (CDM) aids in harmonizing diverse datasets, while federated learning enables privacy-preserving collaborative analyses.

Conclusions:

Advanced statistical and computational methods improve the robustness, interpretability, and regulatory relevance of MS RWD studies.
Integrating complementary statistical approaches within harmonized data infrastructures accelerates the translation of real-world evidence into precision medicine for MS.
The BMSD network is advancing the use of RWD for evidence-based MS care.